Neudle.com: multiple sclerosis primary progressive

Differential
(Click to cross reference)

abducens nerve paralysis

abscess, intracerebral

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adenylate kinase 5 autoantibodies

adverse drug reaction

affect, flat

Alexanders disease

Alexanders disease, adult onset

amphiphysin antibodies

amyloid angiopathy, cerebral

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis, work up

aneurysm

aneurysm, cavernous sinus

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

anti Hu antibody

antibiotics

antihistamines

arterial dissection, aorta

arteriovenous malformation

arteriovenous malformation, cerebral

autoimmune cerebellar ataxia

autoimmune disease

autonomic dysfunction

Barkhof MR criteria for MS

behavioral disorder

Behcet's syndrome

bone marrow biopsy

bone marrow suppression

brain biopsy

brainstem, lesion of

brucellosis, nervous system involvement with

Brudzinski's sign

carbon monoxide poisoning

CAT scan, emission, abnormal

CAT scan, serial

cavernous sinus, syndrome

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellar pontine angle tumor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral peduncle

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular disease

cervical rib

cervical spine

cervical spondylosis

cervical spondylosis, differential diagnosis of

cervical spondylosis, misdiagnosis

chemotherapy, CNS treatment and complications with

Clinical Pathologic Conference(C.P.C.)

clinicoradiologic dissociation

collagen vascular disease

collapsin response mediator protein 5 IgG

complications

concentric sclerosis

confusion

contactin associated protein like 2 antibodies

controversies in neurology

cop 1

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cortical blindness

cost effectiveness

cranial neuropathy

cranial neuropathy, multiple

crying, pathologic

cryptococcal meningitis

cyclophosphamide

cyclosporine

cytomegalovirus infection

degenerative diseases of CNS

delirium

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dermatomyositis

diabetes mellitus

diarrhea

differential diagnosis

diffuse axonal injury

disability rating scale, neurological

disability, neurological

disease modifying agents

drug abuse

drug induced neurologic disorders

electroencephalogram, abnormalities of

electromyogram

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

epidemiology of neurology

facial weakness, bilateral

gammaglobulin therapy, intravenous

ganglionitis

genu of corpus callosum

glioblastoma multiforme(astrocytoma Gr.III)

glioma

gliomatosis cerebri

glutamic acid decarboxylase, antibody

gray matter

Guillain Barre syndrome

head injury

headache

hearing loss

hemianopia, homonymous

hemifacial atrophy

hemiparesis

hemiplegia, progressive

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus infection

herpes zoster

heterochromia iridis

highly active antiretroviral therapy

hippocampal atrophy

hippocampus

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

Horner's syndrome

Horner's syndrome, etiologies of

human immunodeficiency virus type 1

hydrocephalus

hyperreflexia

hypertension

hypertensive encephalopathy

iatrogenic neurologic disorders

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

intellectual deterioration

interferon

interferon beta 1-a

interferon beta 1-b

intracerebral hemorrhage

Jakob-Creutzfeldt disease

JC virus

Kernig's sign

Klumpke palsy

laminectomy, cervical

laughing, pathologic

leucine rich glioma inactivated 1 antibodies

leukodystrophy

leukoencephalopathy

leukoencephalopathy, differential diagnosis

levamisole

level of consciousness, decreased

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

malformation, vascular, cerebral

malignancy screen

malignancy, occult

Marchiafava-Bignami disease

memory, defect of recent

memory, impairment of

mental status, abnormal

mesial temporal lobe

methotrexate

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

miosis

misdiagnosis

mitochondrial disease

mitoxantrone

monoclonal antibodies

mononeuritis multiplex

mononeuropathy

mononeuropathy multiplex

motor neuron disease

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

multiple sclerosis, benign form of

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, tumefactive

mutism

myasthenia gravis, paraneoplastic

myasthenic syndrome

myelopathy

myelopathy, ischemic

myelopathy, necrotizing

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic examination

neurologic practice

neurologic signs

neuromuscular junction

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathy

neuropathy, paraneoplastic

neuropathy, peripheral

neuropathy, sensory

NMDA antagonists

ocrelizumab

onconeural antibodies

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

otitis, neurologic complications with

palatal myoclonus

pancoast tumor

paraneoplastic cerebellar degeneration

paraparesis

paraparesis, spastic

paraproteinemia

paratrigeminal syndrome

peripheral nerve, lesion of

PLEDs, bilateral independent

PLEDs, etiology of

pleocytosis of cerebrospinal fluid

poliomyelitis

polyneuropathy

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

prosopagnosia

pseudobulbar palsy

psychological testing

psychomotor retardation

pulmonary nodules

pupil

pupil, abnormality in neurologic disorders

pyramidal tract

pyramidal tract dysfunction

quadriparesis

quadriplegia

quality of life

radiation therapy, CNS treatment and complications with

radiculitis

rapidly progressing neurologic illness

ReBUILD study

Red flags

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

saccadic eye movements, abnormal

shunt procedure, ventricular

shunt procedure, ventricular-complications of

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spasticity

speech disorder

speech, loss of

spinal cord, compression of

spondylosis

steroid

steroid therapy, CNS treatment and complications with

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

systemic lupus erythematosus

tau protein

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

Thies's sign

thrombocytopenia

thyroiditis

tongue, impaired movements of

tonsillectomy

toxic encephalopathy

toxoplasmosis, acquired

toxoplasmosis, CNS

transient neurologic deficit

treatment of neurologic disorder

trigeminal neuropathy

trigeminal neuropathy, sensory

tuberculosis

tumefactive lesion

tumor necrosis factor

tumor necrosis factor inhibitor

vaccination, neurologic complications with

vaccine

vasculitides

vasculopathy

vertebral-basilar insufficiency

viral infection

viral infection, CNS

viral infection, reactivation

visual evoked response

visual loss

Waldenstrom's macroglobulinemia

walking, difficulty with

white matter, dirty-appearing

workup

xerophthalmia

xerostomia

Showing articles 150 to 200 of 9392 << Previous Next >>

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012

Monosymptomatic Clinically Isolated Syndrome with Sudden Sensorineural Hearing Loss
The Neurologist 18:302-305, Anagnostouli, M.C.,et al, 2012

Solitary Sclerosis
Neurol 78:540-544, Schmalstieg,W.F.,et al, 2012

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

Demographic and Clinical Characteristics of Malignant Multiple Sclerosis
Neurol 76:1996-2001, Gholipour, T.,et al, 2011

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Spectrum of Paraneoplastic Disease Associated With Lymphoma
Neurol 76:705-710, Briani,C.,et al, 2011

Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy
Neurol 77:62-66, Schade van Westrum, S.M.,et al, 2011

Paraneoplastic isolated myelopathy Clinical course and neuroimaging clues
Neurol 76:2089-2095, Flanagan, E.P.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Evidence for Acute Neurotoxicity After Chemotherapy
Ann Neurol 68:806-815, Petzold,A.,et al, 2010

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Clinicopath Conf, The POEMS Syndrome, with Demyelinating Neuropathy and Solitary Pharmacytoma of Bone
NEJM 362:929-940, Case 7-2010, 2010

Increased Tissue Damage and Lesion Volumes in African Americans with Multiple Sclerosis
Neurol 74:538-544,532, Weinstock-Guttman,B.,et al, 2010

Cerebrospinal Fluid Study in Paraneoplastic Syndromes
JNNP 81:42-45, Psimaras,D.,et al, 2010

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Reemergence of PML in Natalizumab-Treated Patients--New Cases, Same Concerns
NEJM 361:1041-1043, Major,E., 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009

Primary Lateral Sclerosis With HIV-1 Infection
Neurol 70:575-577, Verma,A. &Berger,J.R., 2008

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008

Intravascular Large B-Cell Lymphoma
UptoDate, October, Freedman,A.S. &Aster,J.C., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Clinicopath Conf., Anti-MNDAR Antibody Mediated Paraneoplastic Limbic Encephalitis Associated With Ovarian Teratoma
NEJM 359:842-853, Case 26-2008, 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008

Curable Cause of Paraplegia: Spinal Dural Arteriovenous Fistulae
Stroke 39:2756-2759, Aghakhani,N.,et al, 2008

Neurologic Manifestations of Localized Scleroderma: A Case Report and Literature Review
Neurol 71:1538-1545, Kister,I.,et al, 2008

Combining Beta Interferon and Atorvastatin May Increase Disease Activity in Multiple Sclerosis
Neurol 71:1390-1395,1386, Birnbaum,G.,et al, 2008

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Intracranial Hemorrhage in Children
Arch Neurol 65:1629-1633, Lo,W.D.,et al, 2008

Spectrum of Neurological Syndromes Associated with Glutamic Acid Decarboxylase Antibodes: Diagnostic Clues for this Association
Brain 131:2553-2563, Saiz,A., et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008

An Approach to the Diagnosis of Acute Transverse Myelitis
Semin Neurol 28:105-120, Jacob, A.,et al, 2008

Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol 64:1426-1432, de Seze,J.,et al, 2007

Primary Central Nervous System Vasculitis: Analysis of 101 Patients
Ann Neurol 62:442-451,430, Salvarani,C.,et al, 2007

Clinicopath Conf., Multifocal Motor Neuropathy With Conduction Block
NEJM 357: 2707-2715, Case 40-2007, 2007

Showing articles 150 to 200 of 9392 << Previous Next >>